San Diego, CA · Founded 2017 · Privately Held (backing)
Developer of an orally administered toll-like receptor agonist designed to stimulate innate immunity in cancer immunotherapy. Primmune Therapeutics is based in San Diego, CA and was founded in 2017. It was valued at $44 million at its early-stage round in Jan 2021, the last priced event on record. It has raised $63.2 million across 5 recorded rounds; the latest was a $13 million early-stage round in Oct 2020.
PMV mark · valuation
$44.0M
Oct 2026
Priced at
its early-stage round
Jan 2021
Total raised
$63.2M
Last round
Early Stage VC
Oct 2020
Team — not yet on record
No current team members for Primmune Therapeutics are on record yet. People surface from round filings, company disclosures, and coverage sessions.
Pro members can request priority coverage with a 48-hour turnaround.
Free account
More of Primmune Therapeutics with a free account
·Watch Primmune Therapeutics: the Monday email on marks, rounds and moves
